You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 12, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Maria Podbielska1,2, Zdzislaw M Szulc1, Toshio Ariga3
1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Sphingolipid profiles differ between active and inactive multiple sclerosis (MS) lesions. Ceramide 1-phosphate (C1P) may serve as a biomarker for the progressive phase of MS, aiding future treatment strategies.
08:40Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
08:57Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: